• Sickle Cell Treatments Can Destroy Germ Cells in Boys, Affecting Fertility in Adulthood, Study Suggests
  • Approval of Sickle Cell Disease Bill by Senate Committee Welcomed by Emmaus Life Sciences
  • Endari Will Soon Be Available to Sickle Cell Patients in the US Military
  • HRI Protein Identified as Possible New Therapeutic Target for SCD, Study Shows
  • Endari Reduces Pain Crises, Hospitalizations in Sickle Cell Patients, Phase 3 Trial Shows
  • Blood Tests and Funding Can Save African Lives, Especially Children, Official Says
  • White Blood Cells Regulate Levels of Fetal Hemoglobin in Sickle Cell Patients, Study Shows
  • Researchers Raise Funds for Phase 1 Trial to Test Medical Cannabis in Sickle Cell Disease
  • Music Therapy Helps Relieve Pain in Adults with Sickle Cell Disease, Pilot Trial Suggests
  • Kids with Sickle Cell Disease and Sleep Apnea at Higher Risk of Complications, Study Finds
  • First Results from Phase 3 Trial Expected to Support FDA’s Accelerated Approval of Voxelotor for Sickle Cell
  • Gene Therapy LentiGlobin Continues to Show Good Results, Bluebird Bio Says